NewsRx

Search our medical news database

Age-Related Macular Degeneration

Results of implantable telescope trial show potential for treatment of AMD

Published in Medical Letter on the CDC and FDA, December 3rd, 2006

VisionCare Ophthalmic Technologies, Inc. announced that results from the Phase II/III clinical trial of the investigational Implantable Miniature Telescope document a potential new treatment model for an unmet medical need - irreversible vision loss due to bilateral end-stage AMD.

IMT by Dr. Isaac Lipshitz was published in the November issue of Ophthalmology, the official journal of the American Academy of Ophthalmology

The article, entitled "Implantable Miniature Telescope for the Treatment of Visual Acuity Loss Resulting from End-Stage Age-Related Macular Degeneration," details the results from the IMT002 trial which enrolled 217 patients at...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook